Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial.
Takahashi T, Ishida K, Emi Y, Sakamoto M, Imura J, Aishima S, Muro K, Uetake H, Oki E, Katayose Y, Yoshida K, Unno M, Hyodo I, Tomita N, Sugihara K, Maehara Y.
Takahashi T, et al. Among authors: emi y.
Cancers (Basel). 2022 Sep 9;14(18):4392. doi: 10.3390/cancers14184392.
Cancers (Basel). 2022.
PMID: 36139557
Free PMC article.